Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 841-851

  Yehualaeshet, Teshome ^a   O'Connor, Robert ^a   Green Johnson, Julia ^b   Mai, Sabine ^b   Silverstein, Roy ^d   Murphy Ullrich, Joanne E ^c   Khalil, Nasreen ^a,b,e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c University of Alabama at Birmingham   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD36 ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; PLASMIN; PROTEINASE; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; STATISTICAL ANALYSIS;

EID: 0032886794     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65183-8     Document Type: Article

References (52)

1. Rappolee DA, Werb Z: Macrophage derived growth factors. Curr Topics Microbiol Immumol 1992, 181:87-140
2. Stein M, Keshav A: The versatility of macrophages. Clin Exp Allergy 1992, 22:19-27
3. Wahl SM: Transforming growth factor β: the good, the bad and the ugly. J Exp Med 1994, 108:1587-1590
4. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera S, Rifkin DB: TGF-β latency: biological significance and mechanism of activation. Stem Cells 1997, 15:190-197
5. Khalil N, Corne S, Whitman C, Yacyshyn H: Plasmin regulates the activation of cell associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Resp Mol Cell Biol 1996, 15:252-259
6. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 1993, 122:923-932
7. Murphy-Ullrich JC, Schultz-Cherry S, Hook M: Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 1992, 3:181-188
8. Silverstein RL, La Salla J, Pearce SE: CD36 cluster report. Leucocyte Typing V: White Cell Differentiation Antigens. Edited by Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz O, Silverstein RL, Springer TA, Tedder TF, and Todd RF. Oxford, Oxford University Press, 1995, 1271:1274-1275
9. Khalil N, Bereznay O, Sporn MB, Greenberg AH: Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989, 170:727-737
10. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg AH: Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 1993, 92:1812-1818
11. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE: The type-1 repeats of thrombospondin-1 activates latent transforming growth factor-β. J Biol Chem 1994, 269:26783-26788
12. Witman B: On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or α 2-antiplasmin. Thromb Res 1980, 17:143-152
13. 2) secreted by cells in culture. J Cell Physiol 1989, 138:78-86
14. Leung LL, Wei-Xing L, McGregor JL, Albrecht G, Howard RJ: CD36 peptides enhnce or inhibit CD36 thrombospondin binding: a twostep process of ligand receptor interaction. J Biol Chem 1992, 267: 18244-18250
15. Mai S: Overexpression of C-myc precedes amplification of gene encoding dihydrofolate reductase. Gene 1994, 148:253-260
16. Bornstein P: Thrombospondins: structure and regulation of expression. FASEB J 1992, 6:3290-3299
17. Yee JA, Van L, Dominguez JC, Allan EH, Martin TJ: Plasminogen-dependent activation of latent transforming growth factor β(TGF-β) by growing cultures of osteoblast-like cells. J Cell Physiol 1993, 157:528-534
18. Huh YH, Pearch SF, Yesner LM, Schindler JL, Silverstein RL: Regulating expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996, 87:2020-2023
19. Yesner LM, Huh HY, Pearch SF, Silverstein RL: Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vase Biol 1996, 16:1019-1025
20. Trezzini C, Jungi TW, Spycher MD, Maly FE, Rao P: Human monocytes CD36 and CD16 are signalling molecules: evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction. Immunology 1990, 71:29-37
21. Huang MM, Bolen JB, Barnewell JW, Shattil SJ, Brugge JS: Membrance glycoprotein IV (CD36) is physically associated with Fyn, Lyn and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991, 88:7844-7848
22. 1-latency-associated peptide to ligands. Biochem 1997, 36:11923-11932
23. Huber D, Philipp J, Fontana A: Protease Inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J Immunol 1992, 148:277-284
24. Olofsson A, Miyazono K, Kanzaki T, Coloselti P, Engstrom U, Heldin C-H: Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line: identification of small and different forms of large latent complexes, J Biol Chem 1992, 267:1948-1958
25. Mcmahon GA, Dignam JD, Gentry LE: Structural characterization of the latent complex between transforming growth factor β1 and β1-latency-associated peptide. Biochem J 1996, 313:343-351
26. Okada F, Yamaguchi K, Ichihara A, Nakamura T: Purification and structural analysis of the latent form of transforming growth factor-β from rat platelets. J Biochem 1989, 106:3-310
27. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer, TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE: Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin-1. J Biol Chem 1995, 270:7304-7310
28. Arnoletti JP, Albo D, Granick MS, Solomon MP, Rothman NL, Tuszynski AB: Thrombospondin and transforming growth factor β-1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 in human MDA-MB-231 breast cancer cells. Cancer 1995, 76:998-1005
29. Tuszynski GP, Nicosia RF: The role of thrombospondin-1 in tumor progression and angiogenesis. BioEssays 1996, 18:71-75
30. Welgus, HG, Connolly NL, Senior RM: 12-0-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases: high levels of secreted collagenase and collagenase inhibitors accompany low levels of intracellular elastase and cathepsin-G. J Clin Invest 1986, 77:1675-1681
31. Valentine R, Fisher GL: Characteristics of bovine alveolar macrophage elastase. J Leukocyte Biol 1984, 35:449-457
32. Bonner JC, Hoffman M, Brody AR: Alpha2-macroglobulin secreted by alveolar macrophages serves as a binding protein for a macrophage-derived homologue of platelet-derived growth factor. Am J Respir Cell Mol Biol 1989, 1:171-179
33. Souchelnitskiy S, Chambaz EM, Feige JJ: Thrombospondins selectively active one of the two latent forms of transforming growth factor-β present in adrenocortical cell-conditioned medium. Endocrine 1995, 136:5118-5126
34. Anonick PK, Yoo JK, Webb, DJ, Gonias SL: Characterization of the antiplasmin activity of human thrombospondin-1 in solution. Biochem J 1993, 289:903-909
35. Rabhi-Sabile S, Pidard D, Lawler J, Renesto P, Chignard M, Legrand C: Proeolysis of thrombospondin during cathepsin-G induced platelet aggregation: functional role of the 165-kd carboxy-terminal fragment. FEBS Lett 1996, 386:82-88
36. Hogg PJ, Owensby DA, Mosher DF, Misenheimer TM, Chesterman CN: Thrombospondin is a tight-binding, competitive inhibitor of neutrophil elastase, J Biol Chem 1993, 268:7139-7146
37. Murphy-Ullrich JE, Giurusiddappa S, Franzier WA, Hook M: Heparinbinding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J Biol Chem 1993, 268:26784-26789
38. Sipes JM, Giuo N, Negre E, Yogel T, Krutzsch HC, Roberts DD: Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type 1 repeats of thrombospondin. J Cell Biol 1993, 121:469-477
39. Kolset SO, Larsen T: Sulphur-containing macromolecules in cultured monocyte-like cells. Acta Histochem 1988, 84:67-75
40. Driscoll KE, Maurer JK, Higgins J, Poynter J: Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. J Toxicol Environ Health 1995, 46:155-169
41. Vassalli, JD, Wohlwend A, Belin D: Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolylic system. Curr Topics Microbiol Immunol 1992, 181:65-86
42. Clezardin P, Frappart L, Clerget M, Pechoun C, Delmas PD: Expression of thrombospondin (TSP-1) and its receptors (CD36 and 51) in normal, hyperplastic and neoplastic human breast. Cancer Res 1993, 53:1421-1430
43. Daviet L, Mcgregor JT: Vascular biology of CD36: role of this new adhesion molecule family in different disease states. Thromb Haemost 1997, 78:65-69
44. Silverstein RL, Asch AS, Nachman RL: GPIV mediates thrombospondin-dependent platelet-monocyte adhesion. J Clin Invest 1989, 84:546-552
45. Silverstein RL, Baird M, Lo SK, Yesner LM: Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. J Biol Chem 1992, 267:16607-16612
46. Leung, LL: Role of thrombospondin in platelet aggregation. J Clin Invest 1984, 74:1764-1772
47. Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis: J Exp Med 1995. 181:1857-1862
48. Yehaulaeshet T, Douglas D, O'Connor R, Khalil N: In vitro and in vivo inhibition of activation of alveolar macrophage-derived latent transforming growth factor-β 1 (TGF-β1) after bleomycin lung injury. Am J Respir Crit Care Med 1998, 157:A265 (abstr.)
49. Phan SH, Gharaee-Kermani M, Wolber F, Ryan US: Stimulation of rat endothelial cell transforming growth factor-β production by bleomycin. J Clin Invest 1991, 87:148-154
50. Khalil N, O'Connor R, Flanders K, Shing W, Whitman C: Autocrine regulation of type-2 epithelial cell proliferation by transforming growth factor-β during bleomycin induced lung injury in the rat. Am J Physiol 1994, 77:L498-507
51. Cutroneo K, Breen E, Absher M, Phan S: Bleomycin regulation of transforming growth factor-β mRNA in rat lung fibroblasts and subpopulations. Chest 1991, 99:65 (suppl)
52. Munger J, Huang X, Kawakatsu H, Griffiths MJD, Dation SL, Wu J, Pittet J-F, Kaminski N, Garat C, Mathay MA, Rifkin DB, Sheppard D: The integrin αvβ6 binds and activates TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328